Updated safety recommendations have been issued as part of the European review evaluating cases of neural tube defects in babies Read More
Dolutegravir (Tivicay▼, Triumeq▼, Juluca▼): updated advice on increased risk of neural tube defects
Reading Time: < 1 minute